Healthcare -
Biotechnology - NASDAQ - US
$ 1.65
2.48 %
$ 99.1 M
Market Cap
-1.2
P/E
ABOS - STOCK-BASED COMPENSATION
Stock-based Compensation ABOS - Acumen Pharmaceuticals, Inc.
6.14 M
LAST VALUE
158.16%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR